Advertisement
February 2018

February 2018

Welcome to the February issue. Upfront covers an implantable neural device that can deliver drugs with great accuracy, and a study on the inclusion of women in clinical trials. David Harry explains why pharma companies will increasingly rely on software to keep all of their balls in the air in In My View. Our cover feature delves in to the deep waters of biopharmaceutical analysis with four analytical experts as your guide. In Business, we look at how Brexit could impact pharma supply chains, and in Best Practice Adrian Carter calls for pharma to embrace the crowdsourcing phenomenon. Finally, we Sit Down With Nigel Darby of GE Healthcare to discuss destroying saucepans, moving from research to industry, and the rise of biopharmaceuticals.

Recent Issues
Advertisement